Livedo Vasculitis (The Vasculitis of Atrophie Blanche) Immunohistopathologic Study

doi:10.1001/archderm.1975.01630140046003

You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.

Vol. 111 No. 2, February 1975

Online Only
	•	Online First Table of Contents

ORIGINAL CONTRIBUTIONS

•	Online Features

This Article
•	References
•	Full text PDF
•	Reply to article
•	Send to a friend
•	Save in My Folder
•	Save to citation manager
•	Permissions

Citing Articles
•	Citation map
•	Citing articles on HighWire
•	Citing articles on Web of Science (70)
•	Contact me when this article is cited

Related Content
•	Similar articles in this journal

Social Bookmarking
	What's this?

Livedo Vasculitis (The Vasculitis of Atrophie Blanche)

Immunohistopathologic Study

Arnold L. Schroeter, MD; Jose L. Diaz-Perez, MD; Richard K. Winkelmann, MD, PhD; Robert E. Jordon, MD

Arch Dermatol. 1975;111(2):188-193.

Abstract

Hyalinizing segmental vasculitis or livedo vasculitis (atrophieblanche) is a clinical entity with a distinctive immunohistopathologicmorphology that can be distinguished from other forms of cutaneousvasculitis by histologic and direct immunofluorescent studies.Our studies showed that immunoglobulins and complement components(C1q, C3, and properdin) were localized in diseased vessel walls,suggesting an immune pathogenesis.

Author Affiliations

From the Mayo Clinic and Mayo Foundation, Rochester, Minn.

Footnotes

Accepted for publication Aug 8, 1974.

Reprint requests to Mayo Clinic, Rochester, MN 55901 (Dr. Schroeter).

Add to CiteULike CiteULike Add to Connotea Connotea Add to Delicious Delicious Add to Digg Digg Facebook Add to Reddit Reddit Add to Technorati Technorati Twitter What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Successful use of rituximab in a patient with recalcitrant livedoid vasculopathy
Zeni et al.
Ann Rheum Dis 2008;67:1055-1056.
FULL TEXT

Livedoid vasculopathy: further evidence for procoagulant pathogenesis.
Hairston et al.
Arch Dermatol 2006;142:1413-1418.
ABSTRACT | FULL TEXT

Treatment of Livedoid Vasculopathy With Low-Molecular-Weight Heparin: Report of 2 Cases
Hairston et al.
Arch Dermatol 2003;139:987-990.
FULL TEXT

Livedo Vasculopathy vs Small Vessel Cutaneous Vasculitis: Cytokine and Platelet P-Selectin Studies
Papi et al.
Arch Dermatol 1998;134:447-452.
ABSTRACT | FULL TEXT

Livedoid Vasculopathy: What Is It?
Jorizzo
Arch Dermatol 1998;134:491-493.
FULL TEXT

Livedoid Vasculitis: Response to Low-Dose Danazol
Hsiao and Chiu
Arch Dermatol 1996;132:749-751.
ABSTRACT

Livedo Vasculitis: Therapy With Pentoxifylline
Sams
Arch Dermatol 1988;124:684-687.
ABSTRACT

Livedoid Vasculitis and Central Nervous System Involvement in Systemic Lupus Erythematosus
Yasue
Arch Dermatol 1986;122:66-70.
ABSTRACT

Vascular Ulcers in Scleroderma
Thomas and Winkelmann
Arch Dermatol 1983;119:803-807.
ABSTRACT

Cutaneous Periarteritis Nodosa: Immunofluorescence Studies
Diaz-Perez et al.
Arch Dermatol 1980;116:56-58.
ABSTRACT

Cutaneous and Subcutaneous Endarteritis Obliterans
Kossard et al.
Arch Dermatol 1978;114:1652-1658.
ABSTRACT

| | |